SI2318004T1 - Farmacevtski sestavki, ki vsebujejo kristalinično obliko Y posakonazola - Google Patents

Farmacevtski sestavki, ki vsebujejo kristalinično obliko Y posakonazola

Info

Publication number
SI2318004T1
SI2318004T1 SI200930637T SI200930637T SI2318004T1 SI 2318004 T1 SI2318004 T1 SI 2318004T1 SI 200930637 T SI200930637 T SI 200930637T SI 200930637 T SI200930637 T SI 200930637T SI 2318004 T1 SI2318004 T1 SI 2318004T1
Authority
SI
Slovenia
Prior art keywords
posaconazole
pharmaceutical compositions
crystalline form
compositions containing
crystalline
Prior art date
Application number
SI200930637T
Other languages
English (en)
Inventor
Josef Wieser
Arthur Pichler
Andreas Hotter
Ulrich Griesser
Christoph Langes
Christian Laschober
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SI2318004T1 publication Critical patent/SI2318004T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200930637T 2008-06-02 2009-05-28 Farmacevtski sestavki, ki vsebujejo kristalinično obliko Y posakonazola SI2318004T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13072008P 2008-06-02 2008-06-02
EP08157435A EP2130540A1 (en) 2008-06-02 2008-06-02 Pharmaceutical compositions containing a crystalline form of posaconazole
EP09757457.8A EP2318004B1 (en) 2008-06-02 2009-05-28 Pharmaceutical compositions containing the crystalline form y of posaconazole
PCT/EP2009/056574 WO2009147075A2 (en) 2008-06-02 2009-05-28 Pharmaceutical compositions containing a crystalline form of posaconazole

Publications (1)

Publication Number Publication Date
SI2318004T1 true SI2318004T1 (sl) 2013-07-31

Family

ID=39776362

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930637T SI2318004T1 (sl) 2008-06-02 2009-05-28 Farmacevtski sestavki, ki vsebujejo kristalinično obliko Y posakonazola

Country Status (8)

Country Link
US (1) US8563555B2 (sl)
EP (2) EP2130540A1 (sl)
CN (1) CN102046172B (sl)
CA (1) CA2726704C (sl)
DK (1) DK2318004T3 (sl)
ES (1) ES2416485T3 (sl)
SI (1) SI2318004T1 (sl)
WO (1) WO2009147075A2 (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) * 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
CN102892750B (zh) * 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
EP3590505A1 (en) 2015-08-08 2020-01-08 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
EP4424308A2 (en) 2016-02-26 2024-09-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN109260148A (zh) * 2018-10-18 2019-01-25 南京安伦化工科技有限公司 一种高纯度泊沙康唑悬浮液的制备方法
WO2021022103A1 (en) * 2019-07-31 2021-02-04 The Regents Of The University Of Michigan Cocrystals of posaconazole, methods of making and using same
CN111514146A (zh) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 含有泊沙康唑的药物组合物
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
AU2022324717A1 (en) 2021-11-25 2024-06-13 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
AU681753B2 (en) 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
ATE240319T1 (de) 1995-06-02 2003-05-15 Schering Corp Antifungale tetrahydrofurane
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
PL189317B1 (pl) 1997-10-07 2005-07-29 Schering Corp Krystaliczny przeciwgrzybiczy polimorf (-)-4-[4-[4-[4-[(2R-cis)-5-(2,4-difluorofenylo)tetrahydro-5-(1H-1,2,4-triazol-1-ilo-metylo)furan-3-ilo]metoksy]fenylo]-1-piperazynylo]fenylo-2,4-dihydro-2-[(S)-1-etylo-2(S)-hydroksypropylo]-3H-1,2,4-triazol-3-onu
US6713481B1 (en) * 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
EP1372394A1 (en) 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
KR20070027564A (ko) 2004-05-28 2007-03-09 쉐링 코포레이션 포사코나졸을 포함하는 주사가능한 약제학적 현탁액
US20070281011A1 (en) * 2006-05-30 2007-12-06 Elan Pharma International Ltd. Nanoparticulate posaconazole formulations
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole

Also Published As

Publication number Publication date
WO2009147075A2 (en) 2009-12-10
EP2130540A1 (en) 2009-12-09
ES2416485T3 (es) 2013-08-01
CN102046172A (zh) 2011-05-04
EP2318004A2 (en) 2011-05-11
WO2009147075A3 (en) 2010-01-28
CA2726704C (en) 2016-10-25
EP2318004B1 (en) 2013-04-10
US8563555B2 (en) 2013-10-22
DK2318004T3 (da) 2013-07-08
CA2726704A1 (en) 2009-12-10
US20110105525A1 (en) 2011-05-05
CN102046172B (zh) 2013-06-19

Similar Documents

Publication Publication Date Title
SI2318004T1 (sl) Farmacevtski sestavki, ki vsebujejo kristalinično obliko Y posakonazola
IL209196A (en) A crystalline form of posaconazole
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en) Pharmaceutical compositions
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
PL2323623T3 (pl) Kompozycje farmaceutyczne
ZA201106703B (en) Use of pharmaceutical compositions containing mesembrenone
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
ZA200905134B (en) Compositions of stable tiacumicins
HUE044237T2 (hu) Kortexolon-17-alfa-propionátot tartalmazó gyógyszerészeti kompozíciók
EP2552447A4 (en) STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB
EP2332535A4 (en) SOLID PHARMACEUTICAL COMPOSITION
EP2320729A4 (en) GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
IL210102A0 (en) Pharmaceutical compositions of rosuvastatin calcium
IL208325A0 (en) Stabilizing lipis compositions for oral pharmaceutical agents
EP2327406A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION
IL206487A0 (en) Pharmaceutical compositions
GB0902648D0 (en) Pharmaceutical compounds and compositions
GB0908317D0 (en) Pharmaceutical compounds and compositions
HK1182939A1 (en) Stable pharmaceutical composition
HU0700755D0 (en) Pharmaceutical compositions containing capsaicionid
GB0800659D0 (en) Pharmaceutical Compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions